Diagnostic utility and pitfalls of human T‐lymphotropic virus serology in adult T‐cell leukemia/lymphoma: evidence from a 25‐year pathology‐based nonendemic cohort
The Journal of Pathology: Clinical Research · 2026
DOI: 10.1002/2056-4538.70072 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Pathology: Clinical Research, 2026. Verfasst von Chang-Tsu Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department and Graduate Institute of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwa…. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Human T-lymphotropic virus 1, HTLV-I Infections, Human T-lymphotropic virus 2. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Taiwan University Cancer Center.
Abstract (Originalsprache)
Adult T‐cell leukemia/lymphoma (ATLL) is a distinct type of peripheral T‐cell lymphoma (PTCL) driven by human T‐lymphotropic virus type I (HTLV‐1)–infected T cells, but diagnosis can be confounded by histological overlap with non‐ATLL PTCL. While molecular testing is the diagnostic gold standard in endemic areas, HTLV‐1/2 serology is often used as a surrogate in nonendemic settings, yet its accuracy and limitations remain unclear. We retrospectively analyzed 881 PTCL cases over 25 years at two tertiary referral hospitals in Taiwan, where HTLV‐1 is nonendemic. Serology was available in 48.2% of cases. Molecular confirmation was performed using HBZ in situ hybridization and tax quantitative polymerase chain reaction. Among the 44 seropositive PTCL patients with tissue available, 37 were diagnosed and molecularly confirmed as ATLL. Of the seven initially diagnosed as non‐ATLL PTCL, three were reclassified as ATLL, while four showed no molecular evidence, including three likely false seropositives with borderline signal‐to‐cutoff (S/CO) values in serology assay and T follicular helper cell phenotype. In seropositive PTCL, clinicopathologic interpretation without molecular testing yielded 100% positive predictive value, 93% sensitivity, and 93% accuracy, compared with 91% positive predictive value by serology alone. In addition, retrospective molecular screening in 59 PTCL without prior serologic data revealed one case of ATLL that had initially been overlooked. In conclusion, our findings support routine HTLV‐1/2 serologic testing in all newly diagnosed PTCLs. However, interpretation should be guided by clinicopathological correlation and serology index values. Borderline index results warrant molecular confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department and Graduate Institute of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Pathology, National Taiwan University Cancer Center, Taipei, Taiwan.
- Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.
- Department of Pathology and Laboratory Medicine, Nagoya University, Aichi, Japan.
- Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Pathology, Ton-Yen General Hospital, Hsinchu, Taiwan.
ORCID-Profile: Chang-Tsu Yuan, Kung-Chao Chang
Förderung
- National Taiwan University Cancer Center
Zitieren
APA
Yuan, C. T., Sun, L. Y., Chuang, S. S., Karube, K., Yang, H. B., Lee, S. H., Wang, R. C., Chang, K. C., Kao, C. J., Huang, H. H., & Chou, W. C. (2026). Diagnostic utility and pitfalls of human T‐lymphotropic virus serology in adult T‐cell leukemia/lymphoma: evidence from a 25‐year pathology‐based nonendemic cohort. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70072
Vancouver
Yuan CT, Sun LY, Chuang SS, Karube K, Yang HB, Lee SH, et al. Diagnostic utility and pitfalls of human T‐lymphotropic virus serology in adult T‐cell leukemia/lymphoma: evidence from a 25‐year pathology‐based nonendemic cohort. The Journal of Pathology: Clinical Research. 2026. doi:10.1002/2056-4538.70072
BibTeX
@article{Yuan2026,
author = {Yuan, Chang-Tsu and Sun, Li-Yu and Chuang, Shih-Sung and Karube, Kennosuke and Yang, Hsiao-Bai and Lee, Sze-Hwei and Wang, Ren-Ching and Chang, Kung-Chao and Kao, Chein-Jun and Huang, Huai-Hsuan and Chou, Wen-Chien},
title = {Diagnostic utility and pitfalls of human T‐lymphotropic virus serology in adult T‐cell leukemia/lymphoma: evidence from a 25‐year pathology‐based nonendemic cohort},
journal = {The Journal of Pathology: Clinical Research},
year = {2026},
doi = {10.1002/2056-4538.70072}
}
EUVIMED